Pharmaceutical, biopharmaceutical, and veterinary preparations for the treatment of cancer, particularly skin cancer, including melanoma and non-melanoma skin cancer; antibodies and antibody fragments derivatives including human monoclonal antibodies and related fragments conjugated to cytokines.

Pharmaceutical, biopharmaceutical and veterinary preparations for the treatment of cancers, including the targeting of angiogenesis; antibodies and antibody derivatives and fragments, including human monoclonal antibodies and their derivatives and fragments; pharmaceutical and veterinary preparations.